KM Research Hub
← 返回论文库
无 KM 图 入排:待复核 图源:开放图源暂不可得 入排置信度 0.45

Effects of Exercise on Cognitive Impairment in Patients Receiving Chemotherapy: A Multicenter Phase III Randomized Controlled Trial.

Karen M Mustian, Po-Ju Lin, Alisha Chakrabarti, Lindsey J Mattick, Stephen Samuel, Umang Gada, Brian J Altman, Paula M Vertino, Amber S Kleckner, Ian R Kleckner, Joseph J Guido, Chin-Shang Li, Luke J Peppone, Charles S Kamen, Kah Poh Loh, Steven R Rousey, Adedayo A Onitilo, Marianne Melnik, Supriya G Mohile, Michelle C Janelsins

J Natl Compr Canc Netw 24(3) 91-99

PMID41825129
PMCID-
DOI10.6004/jnccn.2025.7118
发表日期2026-03-13
入排依据:The study is a Phase III randomized trial in oncology patients receiving chemotherapy, but its primary endpoints are cognitive impairment and mental fatigue (measured by questionnaires), not a time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, TTP, or analysis using Kaplan-Meier or HR. Therefore, it does not meet the eligibility criterion for a time-to-event endpoint.
PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。
摘要

摘要

BACKGROUND: Up to 75% of patients experience cancer-related cognitive impairment (CRCI) during treatment. CRCI often co-occurs with mental fatigue. Chemotherapy may cause cognitive impairment and mental fatigue by compromising systemic inflammatory responses, whereas exercise may induce a self-regulating inflammatory response and promote immunocompetence. Exercise-induced immunocompetence may lead to improvements in CRCI and mental fatigue. We examined the effects of exercise on CRCI and mental fatigue, as well as the relationships between exercise and CRCI and between inflammatory responses and CRCI, in patients receiving chemotherapy in a multicenter phase III randomized controlled trial. PATIENTS AND METHODS: Patients diagnosed with any cancer type and scheduled to start chemotherapy were randomized to either a 6-week home-based, individually tailored exercise intervention-Exercise for Cancer Patients (EXCAP)-or usual care. The Functional Assessment of Cancer Therapy-Cognitive Function and the Multidimensional Fatigue Symptom Inventory were used to assess cognitive impairment and mental fatigue, respectively. Blood samples were collected to assess inflammation (ie, IL-1β, IL-6, IL-8, IL-10, IFN-γ, and sTNFR1). Analysis of covariance (ANCOVA) was used to examine between-group differences in CRCI and mental fatigue. Structural equation modeling was conducted to examine the relationships between exercise and CRCI and between inflammatory responses and CRCI. RESULTS: Compared with participants receiving usual care, EXCAP participants undergoing chemotherapy on 2-week cycles reported less overall cognitive impairment (mean difference [SE], 7.0 [3.3]; P=.04), perceived cognitive impairment (4.1 [2.1]; P=.05), comments from others identifying cognitive impairment (0.6 [0.2]; P=.02), and mental fatigue (-1.6 [0.5]; P<.01). All EXCAP participants, regardless of chemotherapy cycle duration, reported less mental fatigue compared with participants receiving usual care (-0.7 [0.3]; P=.02). Suppressed inflammatory responses were associated with CRCI in participants receiving chemotherapy (0.2 [0.1]; P<.01). CONCLUSIONS: EXCAP may reduce CRCI and mental fatigue, particularly in patients receiving 2-week cycles of chemotherapy. A healthy inflammatory response, characterized by increases in both proinflammatory and anti-inflammatory cytokines, is associated with less cognitive impairment during chemotherapy.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。